Cargando…

The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents

The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH). The objective of the present study was to evaluate the clinical and predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigamonti, Antonello E., Bondesan, Adele, Rondinelli, Eugenia, Cella, Silvano G., Sartorio, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879448/
https://www.ncbi.nlm.nih.gov/pubmed/35208229
http://dx.doi.org/10.3390/metabo12020155
_version_ 1784658893566115840
author Rigamonti, Antonello E.
Bondesan, Adele
Rondinelli, Eugenia
Cella, Silvano G.
Sartorio, Alessandro
author_facet Rigamonti, Antonello E.
Bondesan, Adele
Rondinelli, Eugenia
Cella, Silvano G.
Sartorio, Alessandro
author_sort Rigamonti, Antonello E.
collection PubMed
description The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH). The objective of the present study was to evaluate the clinical and predictive value of APRI in a paediatric obese population. Seven hundred fifty-seven obese children and adolescents (BMI standard deviation score, SDS: >2.0; age range: 10–18.5 years), not consuming alcohol and without hepatitis B or C, were recruited after having been screened for NAFLD by ultrasonography. A series of demographic, biochemical and clinical parameters was compared between the two subgroups (with or without NAFLD); the same parameters were correlated with APRI; and finally, univariable and multivariable logistic regression was used to evaluate the predictors of NAFLD. NAFLD was diagnosed in about 39% of the entire paediatric population, predominantly in males and in subjects suffering from metabolic syndrome. APRI was correlated with the waist circumference (WC), high-density lipoprotein cholesterol (HDL-C), uric acid, total bilirubin, C reactive protein (CRP) and systolic blood pressure (SBP). Furthermore, APRI was higher in males than females, but independent from steatosis severity and metabolic syndrome. With the univariable analysis, the BMI SDS, triglycerides (TG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), APRI, uric acid and metabolic syndrome were positive predictors of NAFLD, with female sex being negative predictor. At multivariable analysis; however, only BMI SDS, TG, HOMA-IR and APRI were positive predictors of NAFLD, with female sex being a negative predictor. The accuracy of APRI as a biochemical marker of NAFLD was about 60%.In conclusion, in a large (Italian) paediatric obese population, parameters, such as BMI SDS, TG, HOMA-IR and APRI, were positive predictors of NAFLD, with female sex being a negative predictor and most of the prediction explained by APRI. Nevertheless, APRI appears to be a simple biochemical marker of liver injury rather than of NAFLD/NASH and, moreover, is endowed with a limited accuracy for the prediction/diagnosis of NAFLD.
format Online
Article
Text
id pubmed-8879448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88794482022-02-26 The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents Rigamonti, Antonello E. Bondesan, Adele Rondinelli, Eugenia Cella, Silvano G. Sartorio, Alessandro Metabolites Article The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH). The objective of the present study was to evaluate the clinical and predictive value of APRI in a paediatric obese population. Seven hundred fifty-seven obese children and adolescents (BMI standard deviation score, SDS: >2.0; age range: 10–18.5 years), not consuming alcohol and without hepatitis B or C, were recruited after having been screened for NAFLD by ultrasonography. A series of demographic, biochemical and clinical parameters was compared between the two subgroups (with or without NAFLD); the same parameters were correlated with APRI; and finally, univariable and multivariable logistic regression was used to evaluate the predictors of NAFLD. NAFLD was diagnosed in about 39% of the entire paediatric population, predominantly in males and in subjects suffering from metabolic syndrome. APRI was correlated with the waist circumference (WC), high-density lipoprotein cholesterol (HDL-C), uric acid, total bilirubin, C reactive protein (CRP) and systolic blood pressure (SBP). Furthermore, APRI was higher in males than females, but independent from steatosis severity and metabolic syndrome. With the univariable analysis, the BMI SDS, triglycerides (TG), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), APRI, uric acid and metabolic syndrome were positive predictors of NAFLD, with female sex being negative predictor. At multivariable analysis; however, only BMI SDS, TG, HOMA-IR and APRI were positive predictors of NAFLD, with female sex being a negative predictor. The accuracy of APRI as a biochemical marker of NAFLD was about 60%.In conclusion, in a large (Italian) paediatric obese population, parameters, such as BMI SDS, TG, HOMA-IR and APRI, were positive predictors of NAFLD, with female sex being a negative predictor and most of the prediction explained by APRI. Nevertheless, APRI appears to be a simple biochemical marker of liver injury rather than of NAFLD/NASH and, moreover, is endowed with a limited accuracy for the prediction/diagnosis of NAFLD. MDPI 2022-02-08 /pmc/articles/PMC8879448/ /pubmed/35208229 http://dx.doi.org/10.3390/metabo12020155 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rigamonti, Antonello E.
Bondesan, Adele
Rondinelli, Eugenia
Cella, Silvano G.
Sartorio, Alessandro
The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title_full The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title_fullStr The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title_full_unstemmed The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title_short The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents
title_sort role of aspartate transaminase to platelet ratio index (apri) for the prediction of non-alcoholic fatty liver disease (nafld) in severely obese children and adolescents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879448/
https://www.ncbi.nlm.nih.gov/pubmed/35208229
http://dx.doi.org/10.3390/metabo12020155
work_keys_str_mv AT rigamontiantonelloe theroleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT bondesanadele theroleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT rondinellieugenia theroleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT cellasilvanog theroleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT sartorioalessandro theroleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT rigamontiantonelloe roleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT bondesanadele roleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT rondinellieugenia roleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT cellasilvanog roleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents
AT sartorioalessandro roleofaspartatetransaminasetoplateletratioindexapriforthepredictionofnonalcoholicfattyliverdiseasenafldinseverelyobesechildrenandadolescents